Advarra Executive and Leadership Team

Gadi Saarony, the Chief Executive Officer at Advarra, directs the overarching corporate strategy to advance clinical research standards. By aligning life sciences companies, research sites, and investigators, the Chief Executive Officer ensures the integration of safety and technology across all trial phases. Gadi Saarony drives the organizational mission to make clinical trials safer, smarter, and faster through collaborative innovation. This leadership role involves constant engagement with the Board to maintain compliance and operational excellence. By overseeing the expansion of research solutions, the Chief Executive Officer strengthens the market position of the firm. The executive focuses on scaling internal capabilities to meet the evolving demands of global academia and CRO partners. Through rigorous oversight of company-wide performance, Saarony secures long-term growth and maintains the reputation of the organization as a leader in clinical research support.

Jeff Sidell, the Chief Technology Officer at Advarra, architects the digital infrastructure required to modernize clinical research processes. By developing innovative software solutions, the Chief Technology Officer enables research sites and investigators to streamline data management and ensure participant safety. Jeff Sidell drives the integration of advanced technology platforms that support the company's commitment to smarter, faster trial execution. This leadership role involves managing complex technical roadmaps and collaborating with other C-suite leaders to align digital tools with business objectives. By overseeing the deployment of secure, compliant systems, the Chief Technology Officer protects sensitive research data across the global network. Sidell focuses on continuous improvement of the technological ecosystem to maintain a competitive edge in the life sciences industry. Through the application of cutting-edge digital strategies, the executive ensures the firm remains at the forefront of research innovation.

Allie Rozanski, the Chief Revenue Officer & Client Executive at Advarra, directs the commercial strategy to expand the reach of integrated research solutions. By cultivating deep-seated connections across the life sciences industry, the Chief Revenue Officer & Client Executive ensures that CROs and research sites receive tailored support for trial optimization. Allie Rozanski drives revenue growth by identifying new market opportunities and strengthening existing client relationships. This leadership role involves coordinating with the executive team to align sales initiatives with the company's core mission of safety and compliance. By overseeing the client engagement lifecycle, the Chief Revenue Officer & Client Executive secures long-term partnerships that sustain the firm's market impact. Rozanski focuses on delivering value-driven solutions that address the specific needs of investigators and academia. Through strategic market positioning, the executive supports the overall financial health and growth trajectory of the organization.

Swetha Khokale, the Country, Head (India) at Advarra, manages regional operations to support the broader mission of clinical research advancement. Overseeing the expansion of local research site partnerships, the Country, Head (India) ensures that regional teams align with global safety and compliance standards. Swetha Khokale drives the implementation of innovative technologies within the Indian market to optimize trial performance. This leadership role requires close coordination with international stakeholders to integrate regional insights into the global service model. By fostering collaboration between local investigators and life sciences companies, the Country, Head (India) enhances the efficiency of clinical trials. Khokale focuses on building robust operational frameworks that support the unique needs of the regional research landscape. Through strategic management of local resources, the executive contributes to the overall success of the firm in the competitive global research sector.